Eivind Hovig
Eivind Hovig
Professor.1. Centre for bioinformatics. Dept. of Informatics, Univ of Oslo. 2. Oslo Univ. Hosp.
Geverifieerd e-mailadres voor ifi.uio.no
Titel
Geciteerd door
Geciteerd door
Jaar
Database of p53 gene somatic mutations in human tumors and cell lines.
M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sørlie, E Hovig, ...
Nucleic acids research 22 (17), 3551, 1994
12111994
A literature network of human genes for high-throughput analysis of gene expression
TK Jenssen, A Lægreid, J Komorowski, E Hovig
Nature genetics 28 (1), 21-28, 2001
10762001
Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation
M Hollstein, B Shomer, M Greenblatt, T Soussi, E Hovig, R Montesano, ...
Nucleic acids research 24 (1), 141-146, 1996
6171996
Ten simple rules for reproducible computational research
GK Sandve, A Nekrutenko, J Taylor, E Hovig
PLoS Comput Biol 9 (10), e1003285, 2013
5232013
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects
P Hainaut, T Soussi, B Shomer, M Hollstein, M Greenblatt, E Hovig, ...
Nucleic acids research 25 (1), 151-157, 1997
3811997
A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome
B Fromm, T Billipp, LE Peck, M Johansen, JE Tarver, BL King, ...
Annual review of genetics 49, 213-242, 2015
3152015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 66 (3), 464-472, 2017
2722017
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations
AL Børresen, E Hovig, B Smith-Sørensen, D Malkin, S Lystad, ...
Proceedings of the National Academy of Sciences 88 (19), 8405-8409, 1991
2381991
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells
P Ruud, Ø Fodstad, E Hovig
International journal of cancer 80 (1), 119-125, 1999
2351999
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
GM Maelandsmo, VA Flørenes, T Mellingsaeter, E Hovig, RS Kerbel, ...
International journal of cancer 74 (4), 464-469, 1997
2351997
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
TS Alioto, I Buchhalter, S Derdak, B Hutter, MD Eldridge, E Hovig, ...
Nature communications 6 (1), 1-13, 2015
2242015
Screening for germ line TP53 mutations in breast cancer patients
AL Børresen, TI Andersen, J Garber, N Barbier-Piraux, S Thorlacius, ...
Cancer research 52 (11), 3234-3236, 1992
2221992
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 67 (7), 1306-1316, 2018
2102018
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti …
K Bjørnland, JO Winberg, OT Ødegaard, E Hovig, T Loennechen, ...
Cancer research 59 (18), 4702-4708, 1999
2061999
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains
AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ...
Genes, Chromosomes and Cancer 14 (1), 71-75, 1995
2051995
A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies
WP Kuo, F Liu, J Trimarchi, C Punzo, M Lombardi, J Sarang, ME Whipple, ...
Nature biotechnology 24 (7), 832-840, 2006
1812006
p53 abnormalities in different subtypes of human sarcomas
Å Andreassen, T Øyjord, E Hovig, R Holm, VA Flørenes, JM Nesland, ...
Cancer research 53 (3), 468-471, 1993
1681993
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme
GM Mælandsmo, E Hovig, M Skrede, O Engebraaten, VA Flørenes, ...
Cancer research 56 (23), 5490-5498, 1996
1651996
Constant denaturant gel electrophoresis, a modification of denaturing gradient gel electrophoresis, in mutation detection
E Hovig, B Smith-Sørensen, A Brøgger, AL Børresen
Mutation Research Letters 262 (1), 63-71, 1991
1611991
Performance comparison of four exome capture systems for deep sequencing
CSR Chilamakuri, S Lorenz, MA Madoui, D Vodák, J Sun, E Hovig, ...
BMC genomics 15 (1), 449, 2014
1572014
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20